Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie 27. Octobre 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Troubles de la motilité
Néoplasie
Autres
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 1998  Page précédente Page suivante
   
   Articles 1 - 20 / 39956  
   
The Evolution of Neoadjuvant Treatment for Resectable Esophageal Squamous Cell Carcinoma: Past Achievements, Current Standards, and Future Perspectives.
Cancers (Basel)
Ujiie N, Taniyama Y, Sato C, Okamoto H, Ozawa Y, Ishida H, Unno M, Kamei T.
PMID: 42938882 [PubMed]


A Pathological Image-Based Pathomics Signature Combined with Clinicopathological Features for Predicting Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma: A Development and External Validation Study.
Cancers (Basel)
Peng K, Lu J, Zhang P, Zhang W, Fang J, Lin J, Chen S, Kang M.
PMID: 42938785 [PubMed]


Longitudinal peripheral immune dynamics during anti-programmed cell death 1 neoadjuvant therapy in esophageal squamous cell carcinoma.
Front Immunol
Li L, Meng L, Chen X, Li J, Li P, Dong B, Huang C, Zhou W, Li N, Sun G, Li J, Tan G, Jiang L, Tian D.
PMID: 42935930 [PubMed - indexed for MEDLINE]


Neurovascular Retinomics for Noninvasive Profiling of Cancer Risk: A Prospective Cohort Study in the UK Biobank.
Ophthalmol Sci
Zhang SW, Yusufu M, Gong X, Shang X, Gao F, He M, Shi D.
PMID: 42935868 [PubMed]


Definitive radiotherapy versus surgery after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score-matched study of efficacy and safety.
Front Oncol
An Q, Jia Y, Liu M, Fu L, Bai J, Zhang Z, Yan J, Wang Y, Ji H, Su Y, Zhang P, Zhou Z.
PMID: 42935534 [PubMed]


Optimising Expert Pathology Referral in Barrett's Oesophagus Dysplasia Through p53-Guided Triage: A Nationwide Real-World Cohort Study.
United European Gastroenterol J
Weeda YA, van der Wel MJ, Brosens LA, Ooms AHAG, Halfwerk H, Houben MTPM, de Boer OJ, Doukas M, Kate FT, Kats-Ugurlu G, van der Laan J, van Lijnschoten I, Oudijk L, van der Post RS, Raicu MG, Timens W, Timmer B, Visser M, Bergman JJG, Duits L, Meijer SL.
PMID: 42935139 [PubMed - indexed for MEDLINE]


Prognostic Value of Combined Preoperative CALLY and SII Assessment in Patients Undergoing Resection for Esophageal Squamous Cell Carcinoma.
Acta Med Okayama
Xu T, Zheng Y, Huang X, Luo H.
PMID: 42934927 [PubMed - indexed for MEDLINE]


Early detection of esophageal squamous cell carcinoma via a CACNA1E-SNTG1 cfDNA methylation signature.
Clin Epigenetics
Song C, Tang J, Wu H, Shi X, Wu D, Liu J, Shao C, Xu B, Dai L, Li S, Huang C, Shi R, Gu Z.
PMID: 42934728 [PubMed - indexed for MEDLINE]


Position statement from the Asociación Mexicana de Gastroenterología on the early detection and timely referral of gastrointestinal cancer (esophagus, stomach, and colon) in primary care.
Rev Gastroenterol Mex (Engl Ed)
Remes-Troche JM, Cano-Contreras AD, Noble-Lugo A, Valdovinos-García LR, Moreira L, Alfaro-Goldaracena A, Díaz-Romero MC, Hernández-Guerrero A, Hernández-Mondragón OV, Huitzil-Meléndez FD, Leal YA, León-Takahashi AM, Manzano-Robleda MC, Melchor-Ruan J, Noguez-Ramos A, Rosas-Camargo V, Ruiz-García E, Trujillo-Benavides OE, Velarde-Ruiz-Velasco JA, Zamora-Nava LE, Zavala-Cruz GG, Del-Moral-Bernal A, Villaseñor-Hidalgo R, Espinosa-Schoelly A.
PMID: 42934023 [PubMed - as supplied by publisher]


Long-term outcomes and prognostic factors in patients aged 70 years or older with early esophageal squamous cell carcinoma undergoing endoscopic submucosal dissection.
Langenbecks Arch Surg
Li JB, Wei W, Guo S, Li BQ, Feng Y.
PMID: 42931944 [PubMed - indexed for MEDLINE]


The Role of Antinuclear Antibody in Predicting the Efficacy and Immune-Related Adverse Events of Immunochemotherapy in Esophageal Squamous Cell Carcinoma: A Real-World Analysis.
Curr Oncol
Li A, Tao Y, Wang K, Yang H, Yan J, Sun W, Ren W.
PMID: 42930163 [PubMed - indexed for MEDLINE]


Efficacy and Safety of Lucitanib in Advanced Thymic Carcinoma: A Randomized Phase II Trial.
MedComm (2020)
Fang W, Zhou C, Wang C, Wu K, Fu J, Lin X, Zhang H, Chen J, Zhang P, Zhang Y, Tang P, Zheng Y, Liu Y, Zhi X, Gao Z, Fan Q, Cai H, Li F, Guo X, Zhang B, Mu R, Yu Z.
PMID: 42928801 [PubMed]


Neoadjuvant immunotherapy for locally advanced resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis.
BMC Surg
Osman IM, Peng S, Liu H, Zhen W, Ma S, Wang Q.
PMID: 42928166 [PubMed - indexed for MEDLINE]


Establishment of an enteral nutrition pathway for malignant esophageal obstruction using combined esophageal stenting and gastrostomy.
BMC Gastroenterol
Huang W, Lian T, Chen H, Lin B, Qian O, Lu D, Zhuang Z.
PMID: 42928134 [PubMed - indexed for MEDLINE]


Systematic Review and Meta-Analysis of Patients with Esophageal Cancer and Intramural Metastasis.
Ann Thorac Cardiovasc Surg
Sato S, Shimada H, Takeda Y, Endo I, Yoshikawa T.
PMID: 42927908 [PubMed - indexed for MEDLINE]


Alcohol Non-Abstinence and Hypertension as Independent Risk Factors for Esophageal Cancer Recurrence After Endoscopic Submucosal Dissection: A Multicenter Cohort Study.
Kurume Med J
Emori K, Fukunaga S, Mukasa M, Nakane T, Cho T, Minami S, Tanaka H, Ohzono D, Yoshio T, Watanabe Y, Nakano D, Tsutsumi T, Araki T, Morita T, Torimura T, Nouno R, Takedatsu H, Kawaguchi T.
PMID: 42927902 [PubMed - as supplied by publisher]


ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2.
Nature
McGrath L, Kar G, Bonanno L, Guisier F, Insa A, Liberman M, Bylicki O, Livi L, Egenod T, Corre R, Kim DW, Garcia Campelo MR, Provencio Pulla M, Shim BY, Metro G, Bennouna J, Bielska AA, Yohannes AR, Shaju J, He Y, Dowson A, Grenga I, Spicer J, Forde PM, Cascone T.
PMID: 42927884 [PubMed - as supplied by publisher]


Prognostic associations between patient-reported outcomes and progression-free and overall survival in advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 TAP score ≥ 5%: results from the RATIONALE-305 trial.
Qual Life Res
Moehler M, Correa MC, Oh DY, Xu RH, Kato K, Barzi A, Barnes FB, Xu Y, Sheng T, Barnes G, Victor T.
PMID: 42927580 [PubMed - indexed for MEDLINE]


Locoregional and distant recurrence after neoadjuvant chemoimmunotherapy versus chemoradiotherapy in esophageal squamous cell carcinoma: a focused meta-analysis.
BMC Cancer
Ruan Y, Cao W, Long C, Li C, Han J.
PMID: 42926222 [PubMed - indexed for MEDLINE]


A revised postneoadjuvant pathologic stage grouping for esophageal squamous cell carcinoma: A dual-center study.
Eur J Surg Oncol
Geng Z, Li X, Zhou J, Zhang H, Xiao X, Li F, Fang P, Luan S, Zhu W, Peng Y, Zhang L, Wang Z, Qi Y, Yuan Y.
PMID: 42925639 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 39956    Page 1 de 1998  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1